Laboratorios Farmaceuticos Rovi, S.A.
MCE:ROVI.MC
Sector
Location
Market Cap
USD 3.38 B
Share Price
USD 66.02
Avg Daily Volume
112,847
Change (1 day)
1.02%
Change (1 year)
-20.47%
Change (YTD)
1.28%
Laboratorios Farmaceuticos Rovi, S.A. Accounts Payable for the year ending December 31, 2024: USD 89.93 M
Laboratorios Farmaceuticos Rovi, S.A. Accounts Payable is USD 89.93 M for the year ending December 31, 2024, a -24.27% change year over year. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.
-
Laboratorios Farmaceuticos Rovi, S.A. Accounts Payable for the year ending December 31, 2023 was USD 118.76 M, a -10.42% change year over year.
-
Laboratorios Farmaceuticos Rovi, S.A. Accounts Payable for the year ending December 31, 2022 was USD 132.57 M, a 19.56% change year over year.
-
Laboratorios Farmaceuticos Rovi, S.A. Accounts Payable for the year ending December 31, 2021 was USD 110.88 M, a 43.05% change year over year.
-
Laboratorios Farmaceuticos Rovi, S.A. Accounts Payable for the year ending December 31, 2020 was USD 77.51 M, a 0.43% change year over year.
StockViz
Competitors
Roche Holding AG
USD 331.61
RO.SW
+7.43
2.29%
Thermo Fisher Scientific Inc.
USD 489.01
TMO
+3.97
0.82%
Boston Scientific Corporation
USD 103.17
BSX
-0.98
-0.94%
Becton, Dickinson and Company
USD 195.94
BDX
+0.94
0.48%
Fresenius SE & Co. KGaA
USD 53.85
FRE.DE
+0.19
0.35%
Sartorius Stedim Biotech S.A.
USD 207.65
DIM.PA
+1.46
0.71%
bioMérieux S.A.
USD 147.37
BIM.PA
+0.01
0.01%
United Therapeutics Corporation
USD 313.13
UTHR
+1.07
0.34%
Medpace Holdings, Inc.
USD 457.85
MEDP
-0.81
-0.18%
Revvity, Inc.
USD 90.78
RVTY
+1.33
1.49%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 7.61
603392.SS
+0.02
0.24%
Exact Sciences Corporation
USD 45.60
EXAS
+0.61
1.36%
Sysmex Corporation
USD 13.59
6869.T
+0.10
0.73%
Bio-Techne Corporation
USD 53.60
TECH
-0.14
-0.26%
Shenzhen Salubris Pharmaceuticals Co., Ltd.
USD 6.99
002294.SZ
+0.29
4.39%
Key Data
| Date | Accounts Payable | Short-Term Debt | Long-Term Debt | Total Liabilities |
|---|
Competitors
Roche Holding AG
USD 331.61
RO.SW
+7.43
2.29%
Thermo Fisher Scientific Inc.
USD 489.01
TMO
+3.97
0.82%
Boston Scientific Corporation
USD 103.17
BSX
-0.98
-0.94%
Becton, Dickinson and Company
USD 195.94
BDX
+0.94
0.48%
Fresenius SE & Co. KGaA
USD 53.85
FRE.DE
+0.19
0.35%
Sartorius Stedim Biotech S.A.
USD 207.65
DIM.PA
+1.46
0.71%
bioMérieux S.A.
USD 147.37
BIM.PA
+0.01
0.01%
United Therapeutics Corporation
USD 313.13
UTHR
+1.07
0.34%
Medpace Holdings, Inc.
USD 457.85
MEDP
-0.81
-0.18%
Revvity, Inc.
USD 90.78
RVTY
+1.33
1.49%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 7.61
603392.SS
+0.02
0.24%
Exact Sciences Corporation
USD 45.60
EXAS
+0.61
1.36%
Sysmex Corporation
USD 13.59
6869.T
+0.10
0.73%
Bio-Techne Corporation
USD 53.60
TECH
-0.14
-0.26%
Shenzhen Salubris Pharmaceuticals Co., Ltd.
USD 6.99
002294.SZ
+0.29
4.39%